A Hypereosinophilic Syndrome Presenting as Eosinophilic Colitis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Hypereosinophilic syndrome (HES) has three defining features: marked hypereosinophilia for at least 6 months, no confirmed etiology for the eosinophilia, and eosinophilia-related symptoms or organ dysfunction. However, a shorter period of hypereosinophilia with symptoms requiring eosinophil-lowering therapy is also acceptable. We report a case of HES presenting as eosinophilic colitis. Although hypereosinophilia was present for 3 months, this patient needed to be treated with eosionphil-lowering therapy for severe hematochezia. After systemic corticosteroid therapy, symptoms caused by organ involvement were dramatically improved.
Abstract
Hypereosinophilic syndrome (HES) has three defining features: marked hypereosinophilia for at least 6 months, no confirmed etiology for the eosinophilia, and eosinophilia-related symptoms or organ dysfunction. However, a shorter period of hypereosinophilia with symptoms requiring eosinophil-lowering therapy is also acceptable. We report a case of HES presenting as eosinophilic colitis. Although hypereosinophilia was present for 3 months, this patient needed to be treated with eosionphil-lowering therapy for severe hematochezia. After systemic corticosteroid therapy, symptoms caused by organ involvement were dramatically improved.
참고문헌 (17)
- Tefferi A, "Blood eosinophilia: a new paradigm in disease classification, diagnosis, and treatment", Mayo Clin Proc, 80, pp.75~83 (2005)
- Tefferi A, "Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update", Mayo Clin Proc, 85, pp.158~164 (2010)
- Sheikh J, "Clinical overview of hypereosinophilic syndromes", Immunol Allergy Clin North Am, 27, pp.333~355 (2007)
- Rothenberg ME, "Eosinophilia", N Engl J Med, 338, pp.1592~1600 (1998)
- Chusid MJ, "The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature", Medicine, 54, pp.1~27 (1975)
- Shah AM, "Eosinophilic colitis as a complication of the hypereosinophilic syndrome", Postgrad Med J, 63, pp.485~487 (1987)
- Jung HK, "A case of eosinophilic colitis as a complication of the hypereosinophilic syndrome", Korean J Gastrointest Endosc, 18, pp.417~425 (1998)
- Rothenberg ME, "Eosinophilic gastrointestinal disorders (EGID)", J Allergy Clin Immunol, 113, pp.11~28 (2004)
- Fauci AS, "NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations", Ann Intern Med, 97, pp.78~92 (1982)
- Bain B, "Philadelphia chromosome?", Am J Hematol, 82, pp.414~ (2007)
- Cools J, "A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome", N Engl J Med, 348, pp.1201~1214 (2003)
- Rothenberg ME, "Treatment of patients with the hypereosinophilic syndrome with mepolizumab", N Engl J Med, 358, pp.1215~1228 (2008)
- Pardanani A, "Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders", Blood, 101, pp.3391~3397 (2003)
- Klion AD, "Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome", Blood, 103, pp.473~478 (2004)
- Ogbogu PU, "Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy", J Allergy Clin Immunol, 124, pp.1319~1325 (2009)
- Naylor AR, "Eosinophilic gastroenteritis", Scott Med J, 35, pp.163~165 (1990)
- Klion AD, "Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report", J Allergy Clin Immunol, 117, pp.1292~1302 (2006)